Edition:
United States

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

540.55INR
21 Jul 2017
Change (% chg)

Rs-18.90 (-3.38%)
Prev Close
Rs559.45
Open
Rs549.00
Day's High
Rs549.00
Day's Low
Rs537.90
Volume
152,084
Avg. Vol
65,783
52-wk High
Rs699.00
52-wk Low
Rs498.00

Latest Key Developments (Source: Significant Developments)

India's Alembic Pharma June-qtr consol PAT falls
Thursday, 20 Jul 2017 05:00am EDT 

July 20 (Reuters) - Alembic Pharmaceuticals Ltd : :June quarter consol profit after tax 633.8 million rupees versus 1.04 billion rupees year ago.June quarter consol total income 6.48 billion rupees versus 7.37 rupees year ago.  Full Article

India's Alembic Pharma gets FDA nod for generic hypertension drug
Tuesday, 18 Jul 2017 02:41am EDT 

July 18 (Reuters) - Alembic Pharmaceuticals Ltd ::Says ‍received U.S. food & drug administration (USFDA) approval for olmesartan medoxomil and amlodipine tablets​.  Full Article

Alembic Pharmaceuticals gets FDA tentative approval for vardenafil hydrochloride orally disintegrating tablets
Tuesday, 4 Jul 2017 01:10am EDT 

July 4 (Reuters) - Alembic Pharmaceuticals Ltd :Co got US Food & Drug Administration (USFDA) tentative approval for vardenafil hydrochloride orally disintegrating tablets.Says vardenafil hydrochloride orally disintergrating tablets are indicated for the treatment of erectile dysfunction.  Full Article

Alembic Pharmaceuticals gets U.S. FDA approval for amantadine hydrochloride capsules, USP
Thursday, 22 Jun 2017 12:02am EDT 

June 22 (Reuters) - Alembic Pharmaceuticals Ltd :Says received U.S. Food & Drug Administration (USFDA) approval for amantadine hydrochloride capsules, USP.  Full Article

Alembic Pharmaceuticals gets USFDA approval for hypertension drug
Wednesday, 21 Jun 2017 12:46am EDT 

June 21 (Reuters) - Alembic Pharmaceuticals Ltd :Says received US Food & Drug Administration (USFDA) approval for Candesartan Cilexetil tablets 32mg.Says drug used for treatment of hypertension.  Full Article

Alembic Pharma gets FDA nod for generic version of Abbvie's Trilipix
Sunday, 14 May 2017 11:22pm EDT 

May 15 (Reuters) - Alembic Pharmaceuticals Ltd :Says received U.S. Food & drug administration (FDA) approval for fenofibric acid delayed-release capsules.  Full Article

Alembic Pharmaceuticals March-qtr profit rises
Wednesday, 3 May 2017 05:19am EDT 

May 3 (Reuters) - Alembic Pharmaceuticals Ltd :Says recommended dividend of INR 4/share.March quarter consol net profit 930.4 million rupees versus profit 908.3 million rupees year ago.March quarter consol net sales 7.40 billion rupees versus 6.26 billion rupees year ago.  Full Article

Alembic Pharmaceuticals gets US FDA tentative approval for MDD drug
Wednesday, 19 Apr 2017 01:12am EDT 

April 19 (Reuters) - Alembic Pharmaceuticals Ltd :Says Alembic Pharmaceuticals receives USFDA tentative approval for vilazodone hydrochloride tablets.Says drug indicated for treatment of major depressive disorder.  Full Article

Alembic Pharmaceuticals says no 483s issued by FDA for Baroda bioequivalence facility inspection
Monday, 17 Apr 2017 02:55am EDT 

April 17 (Reuters) - Alembic Pharmaceuticals Ltd :Says company's bioequivalence facility located at baroda was inspected by US Food & Drug Administration.Says were no 483s issued by US FDA at end of inspection.  Full Article

Alembic pharmaceuticals says successful US FDA inspection at bioequivalence facility at Baroda
Friday, 10 Mar 2017 03:44am EST 

Alembic Pharmaceuticals Ltd : Says successful US FDA inspection at alembic pharmaceuticals bioequivalence facility at Baroda .Says no 483s issued by US FDA at the end of the inspection bioequivalence facility at Baroda.  Full Article

BRIEF-India's Alembic Pharma June-qtr consol PAT falls

* June quarter consol profit after tax 633.8 million rupees versus 1.04 billion rupees year ago